Durvalumab is an IV drug that boosts the immune system’s ability to detect and kill cancer cells. It’s used to treat a range ...

Esophageal cancer remains one of the world's deadliest cancers, ranking 7th in incidence and 6th in cancer-related deaths ...

The addition of postsurgical atezolizumab immunotherapy to standard-of-care chemotherapy in patients with stage III deficient ...

A weekly phone check-in program for older adults with cancer significantly reduced emergency room visits and hospital stays ...

New data support the role of structured exercise and low inflammatory diets to improve survival and quality of life following ...

Corcept's ALS drug dazucorilant improved survival despite missing the main goal; ovarian cancer drug combo met its target in ...

An exercise program can reduce the risk that colorectal cancer will return after surgery and chemotherapy, according to a new ...